Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes.
Elżbieta ŁuczyńskaTomasz PiegzaJoanna SzporSylwia HeinzeTadeusz PopielaJaromir KargolElzbieta LuczynskaPublished in: Biomedicines (2022)
With breast cancer ranking first among the most common malignant neoplasms in the world, new techniques of early detection are in even more demand than before. Our awareness of tumors' biology is expanding and may be used to treat patients more efficiently. A link between radiology and pathology was searched for in our study, as well as the answer to the question of whether a tumor type can be seen on contrast-enhanced mammography and if such knowledge may serve as part of precision medicine.
Keyphrases
- contrast enhanced
- diffusion weighted
- magnetic resonance imaging
- magnetic resonance
- computed tomography
- diffusion weighted imaging
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- healthcare
- artificial intelligence
- young adults
- dual energy
- machine learning
- patient reported outcomes
- deep learning